Skip to main content

Table 3 Laboratory test results of patients in different groups

From: Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China

 

Groups

V(n = 122)

M(n = 49)

B(n = 33)

MIX(n = 67)

N(n = 229)

P

WBC counts (×109/L)

7.9 ± 3.5

8.4 ± 3.7

7.5 ± 3.4

7.5 ± 3.5

8.7 ± 4.1

>0.05

<4.0 (%)

7(5.7)

5(10.2)

4(12.1)

6(9.0)

12(5.2)

>0.05

4.0 ~ 10.0 (%)

90(73.8)

31(63.3)

24(72.7)

51(76.1)

151(65.9)

>0.05

>10.0 (%)

25(20.5)

13(26.5)

5(15.2)

10(14.9)

66(28.8)

>0.05

Neutrophil (%)

70.6 ± 12.2

70.1 ± 11.0

71.3 ± 13.5

69.0 ± 13.9

69.7 ± 14.5

>0.05

Lymphocyte (%)

20.3 ± 9.8

20.1 ± 8.3

20.5 ± 11.2

21.2 ± 9.9

21.3 ± 11.6

>0.05

Hematocrit (%)

40.9 ± 6.7

39.9 ± 3.9

40.5 ± 5.1

39.3 ± 4.7

40.3 ± 21.7

>0.05

Platelets (×109/L)

209.7 ± 76.8

206.6 ± 65.4

194.6 ± 80.4

202.7 ± 68.0

218.3 ± 66.9

>0.05

Alanine aminotransferase (U/L)

28 ± 22.8

25.0 ± 15.0

45.1 ± 57.0

25.9 ± 20.6

29.3 ± 31.0

>0.05

Aspartate aminotransferase (U/L)

28.3 ± 16.5

26.1 ± 13.1

37.7 ± 37.4

29.4 ± 48.6

26.5 ± 20.1

>0.05

Blood creatinine (μmol/L)

68.7 ± 22.9

64.3 ± 19.5

65.7 ± 14.8

59.8 ± 17.2

66.3 ± 48.3

>0.05

Blood sodium (mmol/L)

137.6 ± 3.7

137.5 ± 4.2

137.8 ± 3

138.0 ± 3.3

138.5 ± 3.4

>0.05

pH

7.4 ± 0.0

7.4 ± 0.0

7.4 ± 0.0

7.4 ± 0.0

7.4 ± 0.1

>0.05

PaO2 (mmHg)

80.3 ± 14.9

79.5 ± 17.6

85.5 ± 50.1

85.2 ± 17.8

82.8 ± 19.8

>0.05

ESR1 (mm)

34.7 ± 26.1

39.7 ± 21.6

43.5 ± 26.4

39.2 ± 23.9

40.9 ± 28.4

>0.05

C-reactive protein (mg/L)

50.7 ± 60

52 ± 42.8

67.5 ± 56.6

58.8 ± 92.2

62.9 ± 61.7

>0.05

Prothrombin time (s)

12.3 ± 2.2

12.5 ± 1.3

12.7 ± 1.7

12.3 ± 1.6

12.7 ± 3.7

>0.05

APTT2(s)

35.8 ± 9.3

35.7 ± 9.5

29.7 ± 6.7

33.1 ± 14.3

32.8 ± 5.7

>0.05

  1. Notes: V: single viral infection; M: single mycoplasma pneumoniae infection; B: single bacterial infection; MIX: mixed infections; N: no pathogen detected. 1ESR, erythrocyte sedimentation rate; 2APTT, activated partial thromboplastin time.